He is co-founder of the Competence Center for Biomolecular Therapeutics, a precompetitive platform at the Medical University of Vienna (who is the main shareholder of this institution) with the pharmaceutical industry which aimed to identify targets for the treatment of inflammatory and immunological diseases.
His international scientific acceptance and recognition in immunology is reflected in the variety of functions in national and international scientific societies and organizations, in which he was elected or asked during his career: He was amongst others President of the Austrian Society for Allergology and Immunology (ÖGAI), board member of the Austrian Science Fund (FWF) and Treasurer of the European Association of Immunological Societies (EFIS).
Furthermore, Hannes Stockinger is executive editor of the scientific journals Immunology Letters and BioMed Research International.
and the contributions to the understanding of signal transduction across the plasma membrane by the lipid-rafts are highly regarded.
For his pioneering research, Hannes Stockinger received numerous prestigious awards, including the Austrian Cross of Honour for Science and Art, 1st Class.